Status | Study |
Withdrawn |
Study Name: Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD Condition: Choroidal Neovascularization Myopia Punctate Inner Choroid Date: 2010-10-29 Interventions: Drug: Bevacizumab (Avastin; Genentech, Inc.) |
Completed |
Study Name: Safety and Efficacy of AIN457 in Noninfectious Uveitis Condition: Active Uveitis That is Not From an Infection. Date: 2008-05-23 Interventions: Drug: AIN457 subcutaneous dose Drug: AIN45 |
Completed |
Study Name: Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy Condition: Coats' Disease Idiopathic Retinal Telangiectasia Retinal A Date: 2007-05-04 Interventions: Drug: ranibizumab injection (0.5 mg) ranibizumab 10mg mg/ml. , 0.3ml/vial, 0.05 ml./injection intravitre |
Completed |
Study Name: Intravitreal Bevacizumab for Inflammatory Neovascular Membranes Condition: Vogt Koyanagi Harada Disease Serpiginous Choroiditis Date: 2006-12-01 Interventions: Drug: Bevacizumab Procedure: Intravitreal |